Global Thrombectomy Devices Market was valued at $982 million in 2016 and is expected to reach $1,389 million by 2027, supported by a CAGR of 5% during the forecast period 2021 – 2027. Thrombectomy devices offer numerous advantages in surrogate endpoints such as biomarker analysis, infarct size reduction, ST-segment resolution, and angiographic thrombolysis of myocardial infarction (TIMI) […]
